Get started
Live feed
SECFilingvia Quantisnow
Kodiak Sciences Inc logo

KOD: SEC Form S-3ASR filed by Kodiak Sciences Inc

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for KOD

Across the 22 sessions after earlier KOD headlines, the stock closed higher 13 times and lower 9 times, with a median move of 4.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

KOD close-to-close change in the session after earlier headlines
SessionEarlier headlineKODSPY
Oct 7, 2026Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026-1.4%-0.2%
Sep 28, 2026Zenkuda and tabirafusp-ted Meet Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Effect with Majority of Patients on 24-week Dosing Interval Using Strict Treat-to-Dryness Real World Retreatment Criteria.and 1 other headline that session+178.0%-0.7%
Sep 24, 2026Goldman resumed coverage on Kodiak Sciences with a new price target+5.4%-0.1%
Aug 14, 2026Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results+3.4%-0.2%
Aug 11, 2026Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema-3.0%-0.3%
Aug 6, 2026Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026+4.1%-0.2%
Quantisnow market dataNASDAQ
Kodiak Sciences Inc logo
KOD
Kodiak Sciences Inc
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2018
Get push alerts for KOD

Follow KOD and get a push notification the moment its next story breaks.

Full KOD profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KOD (Kodiak Sciences Inc) and more on Quantisnow.